Home/Filings/4/0000950170-24-106912
4//SEC Filing

Culleton Bruce 4

Accession 0000950170-24-106912

CIK 0001850270other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 5:31 PM ET

Size

5.7 KB

Accession

0000950170-24-106912

Insider Transaction Report

Form 4
Period: 2024-09-13
Culleton Bruce
DirectorChief Executive Officer
Transactions
  • Award

    Employee stock option (right to buy)

    2024-09-13+500,000500,000 total
    Exercise: $1.69Exp: 2033-12-03Class A Ordinary Shares (500,000 underlying)
Footnotes (1)
  • [F1]This performance-based stock option was granted on December 3, 2023. On September 13, 2024, the Company's board of directors certified achievement of the performance goal at 100%. In addition to the achievement of the performance goal, the options are subject to time vesting requirements under which 25% vested on September 13, 2024 and the remaining 75% vests in equal installments of 125,000 shares on each of November 15, 2024, February 15, 2025 and May 15, 2025.

Documents

1 file

Issuer

PROKIDNEY CORP.

CIK 0001850270

Entity typeother

Related Parties

1
  • filerCIK 0001983742

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:31 PM ET
Size
5.7 KB